HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 997-1,008 of 1,979
Device study icon
CompletedNCT03033420

Reducing the Rate and Duration of Re-ADMISsions Among people with Unipolar Disorder and Bipolarity Using Smartphone-based Monitoring and Treatment - The RADMIS Trials

Official study title

Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS Trials

This study has finished and is no longer accepting participants.

In Copenhagen
Bipolarity, DepressionDevice studyAges 18+
Countries
Denmark
Sponsor
Psychiatric Centre Rigshospitalet
Other study type icon
UnknownNCT02827045

a Vestibular Biomarker of Phase in Bipolarity

Official study title

Exploratory Study of a Vestibular Biomarker of Phase in Bipolar Disorder

Current recruitment status is unconfirmed.

Location not clearly listed
Bipolarity, DepressionObservational studyAges 18–65
Countries
Sponsor
Vest Brain,Centro de Estudios Neurovestibulares
Drug study icon
Active Not RecruitingNCT07047651

CBT and rehabilitation with medication for treatment-resistant schizophrenia or bipolarity

About this title

Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.

Read the official source — NCT07047651
Official study title

The Effectiveness and Efficacy of the Combination of Pharmacotherapy With the Two New Recovery-oriented Programs, RECOVERYTRSGR (Treatment Resistant Schizophrenia) and RECOVERYTRSBDGR (Treatment Resistant Bipolar Disorder)

This study is no longer accepting new participants.

In Athens
Schizophrenia, BipolarityInterventional studyAges 18–65
Countries
Greece
Sponsor
Dr. Stavroula Rakitzi
Behavioral study icon
Active Not RecruitingNCT05877716

EPI-MINN: Targeting Cognition and Motivation - National

Official study title

EPI-MINN: Targeting Cognition and Motivation in Coordinated Specialty Care for Early Psychosis: A National Comparison Study

This study is no longer accepting new participants.

In Minneapolis
Schizophrenia, Bipolarity, ...Device studyAges 15–40
Countries
United States
Sponsor
University of Minnesota
Drug study icon
Active Not RecruitingNCT03573349

Ketamine and brain chemistry changes in treatment-resistant depression

About this title

Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:

Read the official source — NCT03573349
Official study title

Central Versus Peripheral GABA and Glutamate Biomarkers for Treatment Response During Two Infusions of Intravenous Ketamine for Treatment-Resistant Depression

This study is no longer accepting new participants.

In Rochester
Depression, BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Mayo Clinic
Other study type icon
CompletedNCT07043803

Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders

Official study title

Reduction of Anticholinergic Medications Project (RAMP) Among Persons With Schizophrenia or Other Psychiatric Disorders Across UPMC Behavioral Healthcare Partner Organizations Using a Stepped-wedge, Randomized Trial Study Design.

This study has finished and is no longer accepting participants.

Multiple locations, including Altoona
Schizophrenia, BipolarityInterventional studyAges 18+
Countries
United States
Sponsor
University of Pittsburgh

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.